首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Quality Evaluation of Ayurvedic Crude Drug Daruharidra Its Allied Species and Commercial Samples from Herbal Drug Markets of India
【2h】

Quality Evaluation of Ayurvedic Crude Drug Daruharidra Its Allied Species and Commercial Samples from Herbal Drug Markets of India

机译:阿育吠陀粗制药物达鲁哈里德拉相关物种和印度草药市场的商业样品的质量评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Berberis aristata known as “Daruharidra” in Ayurveda is a versatile medicinal plant used singly or in combination with other medicinal plants for treating a variety of ailments like jaundice, enlargement of spleen, leprosy, rheumatism, fever, morning/evening sickness, snakebite, and so forth. A major bioactive marker of this genus is an alkaloid berberine, which is known for its activity against cholera, acute diarrhea, amoebiasis, and latent malaria and for the treatment of oriental sore caused by Leishmania tropica. Although the roots of B. aristata are considered as the official drug (Ayurvedic Pharmacopoeia of India), the study revealed that different species of Berberis, namely. B. asiatica, B. chitria, and B. lycium are also used under the name of Daruharidra in different parts of the country. Detailed physicochemical and phytochemical studies of subjects like total ash, acid insoluble ash, tannins, and total alkaloids were calculated from the shade dried powdered material according to the recommended procedures. Further, heavy metal studies and quantitative estimation of berberine through HPTLC have also been performed as per ICH guidelines. A detailed study of four Berberis species, namely B. aristata, B. asiatica, B. chitria, and B. lycium, which are implicated as Daruharidra and collected from wild and ten commercial samples procured from various important drug markets in India has been carried out, which may be useful to pharmaceutical industries for the authentication of the commercial samples and exploring the possibilities of using other species as a substitute of B. aristata.
机译:小ber属植物在阿育吠陀中被称为“ Daruharidra”,是一种多用途药用植物,可单独使用或与其他药用植物结合使用,用于治疗各种疾病,如黄疸,脾脏肿大,麻风,风湿病,发烧,早/晚病,蛇咬伤和等等。该属的主要生物活性标记是生物碱小ber碱,以其抗霍乱,急性腹泻,阿米巴病和潜伏性疟疾的活性以及治疗热带利什曼原虫引起的东方疮病而闻名。尽管人们认为B. aristata的根是官方药物(印度阿育吠陀药典),但该研究表明,不同种类的小ber。在该国的不同地区,也以达鲁哈里德拉的名义使用了亚洲芽孢杆菌,紫锥芽孢杆菌和枸杞芽孢杆菌。根据推荐的程序,从阴凉干燥的粉末状材料中计算出了诸如总灰分,酸不溶性灰分,单宁和总生物碱之类的详细的理化和植物化学研究。此外,还按照ICH指南进行了重金属研究和通过HPTLC对小ber碱进行定量估计。进行了对四种小a属物种的详细研究,这些属分别为达鲁哈里德拉,从印度的野生动植物和从印度各种重要药品市场采购的十种商业样品中收集而获得,分别属于阿里斯塔塔酵母,亚洲芽孢杆菌,紫锥芽孢杆菌和枸杞芽孢杆菌。 ,这可能对制药行业用于商业样品的鉴定和探索使用其他物种替代牛油杆菌的可能性很有用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号